Loading clinical trials...
Loading clinical trials...
Coronary Microvascular Dysfunction has been consistently shown to play a considerable role in pathophysiology of Ischaemia with non-obstructed coronary arteries (INOCA). While the both diagnoses are i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istanbul University
NCT07093528 · Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction
NCT06991322 · Coronary Microvascular Dysfunction, Coronary Microvascular Disease
NCT06843902 · HIV-1-infection, Coronary Microvascular Dysfunction, and more
NCT05984537 · Coronary Microvascular Dysfunction
NCT05743140 · Coronary Microvascular Disease
Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions